Open access to industry's clinically relevant data - Urgently needed, but when will we get it, and in what form?

被引:11
作者
Herxheimer, A
机构
来源
BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7457期
关键词
D O I
10.1136/bmj.329.7457.64
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:64 / 65
页数:2
相关论文
共 8 条
[1]   GlaxoSmidiKline to publish clinical trials after US lawsuit [J].
Gibson, L .
BRITISH MEDICAL JOURNAL, 2004, 328 (7455) :1513-1513
[2]   Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas [J].
Ioannidis, JPA ;
Lau, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (04) :437-443
[3]  
Medawar C, 2004, LANCET, V363, P2087, DOI 10.1016/S0140-6736(04)16463-5
[4]   Another threat to research in the United Kingdom - Research ethics committees may be unable to function because of political control [J].
Nicholson, R .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7450) :1212-1213
[5]  
*PHARM RES MAN AM, UPD PRINC COND CLIN
[6]  
*PHRMA, 2002, PRINC COND CLIN TRIA
[7]  
RAWLINS MD, 2004, MED OUT CONTROL, P140
[8]   Being a modern pharmaceutical company - Involves making information available on clinical trial programmes [J].
Sykes, R .
BRITISH MEDICAL JOURNAL, 1998, 317 (7167) :1172-1172